DBS
5
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Effect of Physical Activity on the Course of Parkinson's Disease in Patients With Bilateral DBS-STN Stimulation - a Randomized Controlled Trial.
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming
Modulatory Effects of Deep Brain Stimulation on Cerebral Cortical Activity
Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD Patient